All categories

myneva Group acquires SWING to further strengthen its market-leading position in the social software sector


Hamburg, September 18, 2020. BID Equity portfolio firm myneva Group acquires software provider SWING Gesellschaft für EDV-Systemlösungen mbH headquartered in Freiburg (Brsg) and Sursee (Switzerland). SWING has been successful since 1994 serving more than 1,100 customers mainly in southern Germany and Switzerland today. The company will become part of the international myneva Group, where it will […]

BID Equity Fund II announces the acquisition of CRM vendor PiSA sales GmbH to strengthen the recently acquired Infopark Group


BID Equity Fund II, a fund advised by BID Equity, announces the acquisition of Berlin-based PiSA sales GmbH, a leading vendor of Customer Relationship Management (CRM) and Configure Price Quote (CPQ) software. Software from PiSA is used by more than 500 mid-market and large industrial companies. The applications are part of a software stack to […]

BID Equity Fund II acquires majority stake in Infopark Group, creator of the SaaS-based Content Management System Scrivito


BID Equity Fund II, a fund advised by BID Equity, acquires the majority of Infopark Group GmbH. Infopark is the manufacturer of the web-based Content Management Software Scrivito, which is used by well-known organizations in the private and public sector for the creation of highly secure and maintenance-free websites, web applications, portals and apps. As a headless CMS system, Scrivito is offered via APIs as Software as a Service (SaaS) in […]

Final Close of BID Equity Fund II


Hamburg-based private equity firm BID Equity announces the successful final close of BID Equity Fund II. The fund closed at the targeted hard cap volume of €125 million plus a significant commitment by the BID Equity team. BID Equity Fund II was set up as a Luxembourg-based fund structure to cater for the interests of […]

BID Equity Fund II acquires majority stake in XClinical GmbH


BID Equity Fund II, a fund advised by BID Equity, acquires a majority stake in XClinical GmbH. XClinical is a leading international provider of software solutions for drug and medical device studies. The XClinical platform fully implements the CDISC standard, which significantly accelerates the analysis and submission of data to regulatory authorities. XClinical was founded […]

Große Johannisstraße 7
20457 Hamburg, Germany

PHONE +49 40 822 169 420
FAX +49 40 537 981 320